LEVBIO — Level Bio AB (publ) Balance Sheet
0.000.00%
- SEK29.96m
- SEK28.88m
- SEK25.10m
- 26
- 13
- 59
- 20
Annual balance sheet for Level Bio AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | PRESS | ARS | PRESS |
Standards: | SAS | SAS | — | SAS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 1.42 | 5.86 | 7.84 | 3.63 | 1.08 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 3.2 | 8.8 | 5.73 | 4.66 | 6.09 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 9.81 | 21.7 | 20.1 | 13.3 | 11.7 |
Net Property, Plant And Equipment | 0.093 | 0.075 | 0.118 | 0.123 | 0.085 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 9.9 | 32.1 | 28.8 | 19.1 | 15.4 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 6 | 8.15 | 7.69 | 8.03 | 10.8 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 6.9 | 9.95 | 8.91 | 8.68 | 11.2 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 3 | 22.1 | 19.9 | 10.4 | 4.18 |
Total Liabilities & Shareholders' Equity | 9.9 | 32.1 | 28.8 | 19.1 | 15.4 |
Total Common Shares Outstanding |